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SELF MEDICATION: ASSESSMENT OF STATUS, PRACTICES AND PERCEPTION
Saleem F1, Azhar S1, Al-Qazaz HK1, Ahmad N1, Atif M1, Haq N1, Iqbal Q2, Asif M3
1Universiti Sains Malaysia (USM), Pinang, Malaysia, 2University of Balochistan, Quetta,
Balochistan, Pakistan, 3The Islamia University of Bahawalpur, Bahawalpur, Punjab, Pakistan
OBJECTIVES: To determine the status, practices and perception of self-medication
among general population of Quetta city, Pakistan.METHODS: Convenience sam-
ple was taken from respondents that were patrons of community pharmacies. A
questionnaire about status, knowledge and perception against selfmedicationwas
constructed, content validated and used for data collection. Pharmacists were
hired for data collection and analyses were done by SPSS 15. RESULTS: A total of
840 patrons were approached and 784 responded (93.33%). 621 (79.20%) weremales
and 163 (20.79%) were females. Most respondents (74.25%) admitted to practice of
self medication. Males were found to self medicate more (84.36%) than females
(15.63%). Practices of self medication were found more in age group of 35-44
(32.27%). Body weakness/sexual problems (21.80%) were the major conditions for
which self medication was performed. Multivitamins/sexual performance en-
hancer (22.36%), NSAIDS (17.65%) and antibiotics (15.32%) were commonly used
drugs. Information related to the medicines was taken from people with past ex-
posure (25.90%), chemist/pharmacist (20.50%) and family member (18.75%). Most
patients (18.55%) described high physician expenses as the cause of their self med-
ication. A total of 15.67% of the respondents revealed that they trust chemists and
pharmacists more due to their past experiences. A total of 66.65% of population
perceived that self medication helps them save money while 61.25% believed that
selfmedication is harmless.CONCLUSIONS: Educational campaigns to educate the
population about the rational use of medications are needed. The healthcare pro-
fessionals must pay special attention on this issue. In addition, sale of medicines
without prescriptions should be strictly prohibited and monitored by regulatory
authorities.
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THE ASSOCIATION OF MENOPAUSAL SYMPTOMS, INCLUDING HOT FLASHES,
WITH QUALITY OF LIFE, WORK PRODUCTIVITY AND RESOURCE USE
Wagner JS1, DiBonaventura MD1, Shah S2, Alvir J2, Whiteley J2
1Kantar Health, New York, NY, USA, 2Pfizer, Inc., New York, NY, USA
OBJECTIVES: The current study characterizes health-related quality of life
(HRQoL), work productivity, and resource use among women experiencing meno-
pausal symptoms, including hot flashes. METHODS: The study is based on data
from the 2005 US National Health and Wellness Survey (N  41,184), which is a
cross-sectional, internet-based survey representative of the adult US population.
Women who were aged 40-64, did not report a history of cancer, and provided
information regarding the presence of menopausal symptoms were included for
analyses (N8578). Women who reported currently experiencing menopausal
symptoms, including hot flashes (n3767), were compared with women who did
not report currently experiencingmenopausal symptoms (n 4499), controlling for
demographic and health characteristics. Outcomesmeasures included HRQoL (SF-
8), work productivity (WPAI) within the past 7-days, and healthcare resource use
within the past 6-months. Normally distributed variables were assessed withmul-
tiple regressions, while non-normally distributed variables were assessed with
generalized linear models. RESULTS: There was little difference in themean age of
women experiencing hot flashes (50.5 yrs, SD5.2), and women not reporting
menopausal symptoms (49.1 yrs, SD6.5). After controlling for demographic and
health characteristics, women experiencing hot flashes reported significantly
lower mental (46.8 vs. 48.5, p.0001) and physical (45.8 vs. 47.3, p.0001) function-
ing on the SF-8 component summary scores than women not experiencing meno-
pausal symptoms. In addition,mean percent impairment while at work (25.00% vs.
14.32%, p.001), and in activities of daily living (37.32% vs. 23.16%, p.0001) were
higher among women experiencing hot flashes. Furthermore, the annual mean
number of ER visitswere higher among thosewithmenopause (2.1 vs. 1.9, p.0428).
CONCLUSIONS: The presence of menopausal symptoms, including hot flashes,
was independently and significantly associated with lower levels of mental and
physical HRQoL, lower productivity, greater impairment in activities of daily living,
and greater resource utilization.
Individual’s Health – Health Care Use & Policy Studies
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IMPLEMENTATION OF A STATE MEDICAID PRESCRIPTION CAP POLICY: IS
THERE AN IMPACT ON BENEFICIARIES’ MEDICAL SERVICES UTILIZATION AND
COSTS?
Khanna R, Dharmarajan SH, Null KD, Bentley JP, Pace PF, Banahan BF
University of Mississippi, University, MS, USA
OBJECTIVES:On July 1, 2005,Mississippi (MS)Medicaid implemented a prescription
cap policy restricting the number of prescriptions filled by a beneficiary during a
month to five. The purpose of this study was to examine the effect of this policy on
overall medical services utilization and costs. METHODS: For the purpose of this
study, a retrospective analysis of the 2004–2006 MS Medicaid fee-for-service (FFS)
administrative claims data was performed. The study included two data periods:
12-month pre- and post-prescription cap date of July 1, 2005. In both study periods
(July 1, 2004 to June 30, 2005 [pre-cap] and July 1, 2005 to June 30, 2006 [post-cap]),
beneficiaries who were 21 to 64 years of age during the 12-month period and were
continuously enrolled for 10 months or more were identified. A final set of 89,110
(pre-cap cohort) and 87,518 (post-cap cohort) beneficiaries remained after applying
the study inclusion and exclusion criteria. Using segmented regression analysis,
trends in medical services utilization and cost per beneficiary per month (PBPM)
were examined over the two-year period. RESULTS: In the 12-month period before
the implementation of the cap, a decreasing trend in ER visits was observed (coef-
ficient-0.0024, p0.0001). The implementation of the cap resulted in an initial
increase in the utilization of ER visits (coefficient0.0160, p0.0001; absolute dif-
ference0.0167 visits PBPM). When examining the ER visit costs, a decreasing
month-to-month trend was observed in the 12-month pre-cap period (coeffi-
cient-2.4651, p0.001). The implementation of the cap resulted in a decrease in
ER visit costs (coefficient-20.554, p0.0001). However, an increasing month-to-
month trend in ER visit costs was observed in the 12-month post-cap period (coef-
ficient1.332, p0.0008). Results for hospitalization and office visit utilization and
costs revealed no significant findings. CONCLUSIONS: There was an increase in ER
visits utilization among MS Medicaid beneficiaries after the prescription cap im-
plementation.
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PHARMACISTS’ ATTITUDE AND PREPAREDNESS REGARDING THE ISSUE OF
ESCALATING PHARMACEUTICAL DEMAND DUE TO THE AGING BABY BOOMERS
Makhija D1, Sansgiry S2, Johnson ML2, Essien EJ2
1HERON Evidence Development LLC, Somerville, NJ, USA, 2University of Houston, Houston, TX,
USA
OBJECTIVES: To assess and evaluate the association between pharmacists’ atti-
tude, perceived preparedness, and willingness to prepare regarding the issue of
escalating pharmaceutical demand due to the aging baby boomers. METHODS:
Thiswas a non-experimental, cross-sectional, field study design. The study sample
consisted of registered pharmacists’, practicing in chain and independent commu-
nity pharmacy stores in Houston and surrounding areas. A self-administered sur-
vey questionnaire based on the proposed model for the study was developed to
address the study objectives. Descriptive analysis followed by paired t-tests (de-
pendent sample); wilcoxon signed-rank tests (independent sample) and spearman
correlation analysis were performed to assess the study objectives. RESULTS: A
total of 117 pharmacists’ responded with an overall response rate of 49.8%. Mean
age of the respondents was 41.1 (11.1) years, withmajority being females (51.7%),
African Americans (41.0%), having an average experience of 13.6 (SD  11.6) years,
working in chain pharmacy setting (77.8%), having a PharmD degree (55.7%) and
working full time (91.4%). Non-respondents matched the sample on the gender
(p0.75) and practice setting (p0.84). Approximately 60% pharmacists’ rated their
current workload level as high, with 92% believing their workload level to signifi-
cantly increase given the rise in the aging baby boomer population over the next
two decades. However, nearly 56% pharmacists’ believed that the potential
changes in workload will not affect their job, patient-care and health related out-
comes. Also, approximately 83% pharmacists’ agreed to be prepared and willing or
verywilling to take action, whatever itmay be, to better prepare themselves for the
aging baby boomer population. CONCLUSIONS: Pharmacists’ attitude and per-
ceived preparedness were found to be significantly associated with their willing-
ness to prepare for the aging baby boomer population. Further studies are required
to assess the effect of various covariates on pharmacist’s willingness to prepare for
the aging baby boomer population.
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DRUG PRESCRIBING BEHAVIOR FOR THE TREATMENT OF HEAVY MENSTRUAL
BLEEDING
Hawryluk EA, Horowicz-Mehler N, Popli M
Quintiles, Hawthorne, NY, USA
OBJECTIVES: Heavy menstrual bleeding (HMB) is defined as excessive menstrual
bleeding which interferes with a woman’s quality of life. Despite availability of
surgical and non-surgical treatments, HMB remains a public health issue with a
prevalence of 4-10%. The objective was to examine why many women do not
receive medication to treat their HMB. METHODS: The number of visits to physi-
cian offices for HMB (ICD-9 code 626.2) in 2009 was collected using SDI’s Physician
Drug and Diagnostic Audit (PDDA). Additional visit-level data was collected
through PDDA, including: the number of visits resulting in a prescription for HMB,
the number of visits where patients requested a prescription and other confound-
ing variables such as 1st or subsequent visit, disease severity and comorbidities.
The impact of these factors on the likeliness of a patient receiving a prescription for
the treatment of HMB was explored. Surgical treatments were not considered in
this analysis. RESULTS: In 2009, there were 2,341,000 patient visits to physicians
where the primary focus of the visit was the patient’s HMB. Overall, patients re-
ceived a prescription for the treatment of their HMB in 59% of visits. Among the
visits with a prescription, only 18% of prescriptions were requested by the patient.
Yet, those who requested a prescription were more likely to receive one (73% vs.
57%). Differences existed between prescription and non-prescription groups. GPs
were more likely to prescribe for HMB than OB/GYNs (77% vs. 58%). Patients were
more likely to request drugs on their first visit versus subsequent doctor visits (54%
vs. 46%). CONCLUSIONS: This preliminary analysis demonstrates that although pa-
tient visits for HMB are relatively common, few women are actually requesting treat-
ment for their HMBandnot all receivemedication for their disease. There is a need for
further research to determine the factors that contribute to this discrepancy.
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DUAL VETERAN HEALTH ADMINISTRATION AND MEDICARE USE AND
AMBULATORY CARE SENSITIVE HOSPITALIZATIONS
Ajmera MR, Wilkins TL, Sambamoorthi U
West Virginia University, Morgantown, WV, USA
OBJECTIVES: The objective of the study is to examine the association between
ambulatory care sensitive hospitalizations (ACSH) for and fragmented care as rep-
resented by dual Medicare/Veteran Health Administration (VHA) use. METHODS:
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The study involves cross-sectional analyses of 44,957 veterans and non-veterans
enrolled in Medicare. Merged Medicare claims for fee-for service enrollees and
survey data from multiple years of the Medicare Current Beneficiary Survey from
2001 through 2005. ACSH for thirteen conditions were identified using inpatient
Medicare claims and an algorithm developed by the Agency for Healthcare Quality,
which uses International Classification of Diseases, 9th edition codes. Dual use was
defined as having inpatient or outpatient visits to the VHA and consisted of pre-
dominant-VHA use and some VHA use. Unadjusted group differences in any ACSH
were tested using chi-square tests. Logistic regressions were used to analyze the
association between dual VHA use and ACSH after controlling for demographic,
socio-economic, health status, mental illness, smoking and obesity. All analyses
accounted for the complex design of the survey. RESULTS: The three most com-
mon ACSH were congestive heart failure, bacterial pneumonia, and chronic ob-
structive pulmonary disease. Among inpatient users, 10.1% had ASCH for acute
conditions and 15.8% for chronic conditions. Among all survey respondents, 5%
had any ACSH; the rates were 4.9% for VHA users and 3.7% for veterans with some
VHA use. In bivariate and multivariate analyses, dual use was not significantly
associated with any ACSH. CONCLUSIONS: In a representative sample of Medicare
beneficiaries, ACSHwere prevalent. Despite poor health status, dual VHA/Medicare
use was not associated with increased ACSH rates perhaps due to the provision of
good primary care in the VHA system.
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EPIDEMIOLOGY OF ADOLESCENT AND YOUNG ADULT HOSPITAL UTILIZATION
FOR ALCOHOL AND DRUG USE, SUICIDE, AND POISONING IN THE UNITED
STATES
Barnard M, Banahan BF
University of Mississippi, University, MS, USA
OBJECTIVES: Adolescence and young adulthood are an important transitional pe-
riod during which morbidity and mortality often arise from individual’s behaviors
such as alcohol and drug use, suicide, and poisonings. Self-report survey data
regarding health behaviors are readily available, however little data from objective
sources has been reported and minimal study of health care utilization, particu-
larly hospital utilization, related to these behaviors has been conducted. This study
examines the patterns and characteristics of individuals admitted to the hospital
for these conditions.METHODS: The data for this investigation came from the 2007
National Hospital Discharge Survey (NHDS). Records for all individuals who had an
age in the range of 10-24 years and were discharged from the hospital with any
recorded diagnosis of alcohol or drug abuse or dependence, suicide, or poisonings
were abstracted. National estimates were calculated utilizing the weighted num-
ber of discharges and the U.S. Census Bureau population data for this age group.
Rao-Scott Chi square tests were performed to evaluate differences between groups
and all significance tests were two-sided using p0.05 as the level of statistical
significance. RESULTS: National estimates for hospital discharges per 1,000 10-24
year olds are 54.2 for alcohol/drug use, 3.3 for suicide, and 9.8 for poisoning. Sea-
sonal trends in alcohol/drug and suicide discharges were observed, as were re-
gional differences with more than twice as many alcohol/drug-related discharges
in the South. Over 42% of all care related to these diagnoses is expected to be paid
for by public health insurance programs. Self-pay is also high for these conditions
(16.1%). CONCLUSIONS: A significant porition of inpatient hospital care for adoles-
cents and young adults is attributable to alcohol/drug use, suicide, and poisonings.
These data have implications for primary intervention programs and suggest the
need for further investigation of the associated health care costs related to these
conditions.
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THE EFFECT OF ELECTRONIC-MEDICAL-RECORD SYSTEM SOPHISTICATION ON
PREVENTIVE HEALTH CARE FOR WOMEN
Tundia N1, Heaton P1, Cavanaugh T1, Guo JJ2, Hanseman D3, Kelton CM1
1University of Cincinnati, Cincinnati, OH, USA, 2University of Cincinnati College of Pharmacy,
Cincinnati, OH, USA, 3University of Cincinnati Medical Center, Cincinnati, OH, USA
OBJECTIVES: Electronic-medical-record (EMR) systems have the potential for im-
proving the quality of preventive healthcare forwomen, by reminding patients and
physicians to obtain appropriate screenings and vaccinations, and decrease
health-care costs significantly by preventing emergency-department visits and
hospitalizations. The objective was to study the effect of EMR-system sophistica-
tion on women’s healthcare in physician offices. METHODS: The National Ambu-
latory Medical Care Survey (NAMCS), a cross-sectional database of physicians’ of-
fice-based visits was analyzed. Based on several of the NAMCS questions, EMR-
systems were classified into nonexistent, minimal, basic, and fully functional
systems according to their set of specific functions. Visits were selected provided
that (1) they were made by a woman  18 years old and (2) the visit was not for a
chronic or acute illness as identified by the visit’s ICD-9 code. Preventive health-
care provision included screenings (mammography and bone-mineral-density im-
aging); exams (breast and pelvic); tests (PAP tests and tests for chlamydia, choles-
terol, and blood pressure); and vaccinations. Estimated frequencies of preventive
health services ordered or completed by the physician were for the four levels of
EMR-system sophistication. RESULTS: In 2007-08, 341,729 physicians ordered or
provided 2.56, 1.31, 1.97, and 1.82million preventive healthcare exams, screenings,
tests, and vaccinations for women aged 18-39, 40-49, 50-64, and 65, respectively.
The ratios of number of preventive women’s healthcare measures to number of
visits bywomen, for practiceswith no EMRwere the lowest (1.12, 1.21, 1.25 and 0.28
for age-groups 18-39, 40-49, 50-64, and 65, respectively). Whereas, practices with
fully-functional EMR systems had the highest ratios, (1.5, 1.54 and 0.48 for age-
groups 18-39, 50-64 and65, respectively), except for the 40-49 age group, forwhich
minimal-EMR-system practices had the highest ratio of 1.61. CONCLUSIONS: Evi-
dence suggests that the more sophisticated the EMR system, the greater the inten-
sity of preventive healthcare service provided to women.
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RETROSPECTIVE DATABASE ANALYSIS OF TREATMENT PATTERNS AND
HEALTH CARE COSTS AMONG WOMEN WITH IDIOPATHIC HEAVY MENSTRUAL
BLEEDING
Pocoski J1, Law A1, Zampaglione E1, Le Nestour E2, Copher R3
1Bayer HealthCare Pharmaceuticals, Inc., Wayne, NJ, USA, 2i3 Research, Paris, France,
3i3 Innovus, Eden Prairie, MN, USA
OBJECTIVES: Assess real world treatment patterns, health care utilization, and
costs of HMB patients. METHODS: Data were administrative claims from a large
national US health plan. Female plan enrollees aged 18-49 with at least 2 claims of
HMB (ICD-9-CM 626.2, 627.0) within 180 days during 01-01-04 to 02-29-08 were
included; index date was initial HMB claim. Continuous enrollment required 6mos
pre-index and 18mos post-index. Patientswere classified as idiopathic HMBunless
underlying conditions associated with HMB occurred in pre-index or 60 days post-
index date. All variables were analyzed descriptively. Multivariate analyses were
conducted to evaluate the factors associated with follow-up HMB-related costs.
RESULTS: Mean [SD] age of the study population (N21,239) was 39.5 [6.8]; mean
[SD] comorbidity score was 0.14 [0.42]. Of the 21,239 women, 57.6% had 1 treatment
episode, 15.7% had 2 or more, and 26.6% had no treatment during the post-index.
15,582 patients received treatment, the distribution of initial treatment was 36.4%
received medication (oral contraceptive [OC], non-OC, or oral medroxyprogester-
one acetate [MPA]), 50.8% had endometrial ablation [EA], and 12.6% underwent
hysterectomy. Mean [SD] HMB-related costs of single episode paths were: hyster-
ectomy $8,656.84 [$5,453.34]), EA $4,579.63 [$3,509.16], and no treatment $616.23
[$946.73]. On average follow-up HMB-related costs are expected to be 9.67 times
greater for womenwithmultiple episodes and 6.33 times greater for single episode
(ref. group: no treatment). Age, Charlson comorbidity score, geographical region
were also associated with higher total follow-up HMB-related costs whereas base-
line OC use and pregnancy during the follow-up lowered costs. CONCLUSIONS:
HMB has significant clinical and economic impact. Over 1/4 of patients did not
receive treatment. Prevalence of surgical procedures was high among those
treated, often constituting first-line treatment. Surgical procedures and multiple
treatment episodes were associated with higher HMB-related costs.
Individual’s Health – Research on Methods
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SUCCESSFUL SEXUAL INTERCOURSE: TIME-TO-EVENT MODELING IN A
SILDENAFIL TRIAL
Cappelleri JC1, Bushmakin AG1, Stecher V2, Symonds T3
1Pfizer, Inc., New London, CT, USA, 2Pfizer, Inc., New York, NY, USA, 3Pfizer Ltd. Outcomes
Research, Sandwich, Kent, UK
OBJECTIVES: Patients with unmet expectations for the time required to experience
improvement (or sustained improvement) with treatment may prematurely dis-
continue otherwise effective treatment. We assessed median time to successful
sexual intercourse (SSI) with sildenafil and placebo. METHODS: Successful sexual
intercourse was assessed in an 8-week, double-blind, placebo-controlled trial of
sildenafil treatment in men with erectile dysfunction. SSI for each episode of sex-
ual activity was defined by patient report and by two events: 1) the subject at-
tempted sexual intercourse and 2) the subject had an erection lasting long enough
for successful intercourse. Median time to SSI was calculated for two types of
events: 1) time to the first SSI (transient event) and 2) stable SSI (initial improve-
ment sustained for the remainder of the double-blind 56-day study, defined as at
least 50% of sexual intercourses being successful until the end of the study). Log-
rank tests compared time-to-event curves between treatment groups.RESULTS:Of
288 men enrolled, 95 received placebo, 99 received sildenafil 100 mg, and 94 re-
ceived sildenafil 50 mg. Median time from the start of the study to achieve initial
SSI was 3 days for each group of sildenafil-treated patients (50 mg and 100 mg),
compared with 13 days for placebo-treated patients (P0.001). (Note that not ev-
eryone attempted sexual intercourse on the first day of treatment.) Median time to
achieve stable (sustained) SSI was 5 days (50 mg) and 3 days (100 mg) for sildenafil-
treated patients versus 55 days for placebo-treated patients (P0.001).
CONCLUSIONS: This novel application of time-to-event analysis provides useful
timeframes for when patients can expect to see initial and then stable improve-
ments with sildenafil treatment. Median times to initial SSI and sustained SSI were
significantly shorter for sildenafil-treated vs placebo-treated men.
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A NET BENEFIT FRAMEWORK (NBF) ANALYSIS OF CHART DATA FOR
HAEMOPHILIA INHIBITOR PATIENTS
Weatherall J1, Mesterton J2, Lindgren P3, Dalen J2
1Novo Nordisk A/S, Soeborg, Denmark, 2i3 Innovus, Stockholm, Sweden, 3i3 Innovus, San Diego,
CA, Sweden
OBJECTIVES: Effective treatment of bleedings in hemophiliac patients is important
for limiting costs associated with bleedings and for improving health outcomes.
Two health outcomes of interest is the time from treatment initiation to bleeding
resolution and the probability of developing re-bleedings. The objective of this
study was to develop a methodology with NBF instead of the ICER for estimating
the health economic benefits of a novel treatment with certain characteristics
compared to rFVIIa and to identify the major determinants of the net monetary
benefit of the novel treatment. METHODS: Data from a medical chart review on
hemophilia inhibitor patients in Turkey were used to identify predictors of the
A112 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) A 1 – A 2 1 4
